Skip to main content

Table 1 Differentially expressed proteins identified by MS after 2-DE

From: Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma

Spot No. Protein Name Accession Number (NCBI) MW(Da) pI MASCOT score Total Ion Score C.I. % Location
S7 fibrinogen gamma chain gi|119625323 37714 5.87 177 100 T1,T2
S8 fibrinogen beta chain gi|119625344 39711 6.95 137 100 T1,T2
S9 lactate dehydrogenase B gi|119616854 36615 5.71 104 99.9988 T1,T2
S10 Apo-A1 gi|490098 28061 5.27 235 100 T1,T2
S11 Apo-A1 gi|490098 28061 5.27 207 100 T1,T2
S12 Clusterin gi|42740907 52461 5.89 102 99.9565 T1,T2
S13 hp2-alpha gi|296653 41499 6.25 115 98.9869 T1,T2
S16 fibrinogen gamma chain gi|119625325 35480 6.07 100 100 T1
  1. T1: the protein expression increased in urine samples from patients with low malignant BTCC;
  2. T2: the protein expression increased in urine samples from patients with aggressive BTCC.